Clinical trialNCT01978730UnknownPhase 2Interventional

The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule

SponsorShineway Pharmaceutical Co.,LtdEnrollment372Vascular Dementia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

As a traditional Chinese medicine compound, SaiLuoTong capsule is proven to have beneficial effects on learning and memory ability in animal models of vascular dementia (VaD). The study hypothesis is that SaiLuoTong capsule will be effective in the treatment of patients with VaD and will be well tolerated. The purpose of the study is to determine the efficacy and safety of SaiLuoTong capsule on patients with mild to moderate VaD. The outcome measures include general cognitive function, executive function, daily living skills, and mental behavior changes of symptoms in VaD patients.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Baojun Wang, Doctor
the chief of of the neurology department, Central Hospital of Baotou
Study Chair
clinicaltrials.gov ↗
Benyan Luo, Doctor
the chief of the neurology department, the First Hospital of Zhejiang University
Study Chair
clinicaltrials.gov ↗
Changshan Ai, Master
the chief of the neurology department, Hospital of Traditional Chinese and Western Medicine of Jilin Province
Study Chair
clinicaltrials.gov ↗
Desheng Zhou, Doctor
the chief of the neurology department, First Hospital of Hunan University of Chinese Traditional Medicine
Study Chair
clinicaltrials.gov ↗
Dongdong Yang, Doctor
the chief of the neurology department, the Affiliated Hospital of Chengdu Chinese Traditional Medicine
Study Chair
clinicaltrials.gov ↗
Jiang Wu, Doctor
the chief of the neurology department, the First Hospital of Jilin University
Study Chair
clinicaltrials.gov ↗
Jianming Lv
the chief of the neurology department, the First Hospital of Tianjin University of Chinese Traditional Medicine
Study Chair
clinicaltrials.gov ↗
Jianping Jia, professor
the chief of the neurology department, Xuan Wu Hospital of Capital Medical University
Principal Investigator
clinicaltrials.gov ↗
Jimei Li, Bachelor
the chief of the neurology department, Beijing Friendship Hospital of Capital Medical University
Study Chair
clinicaltrials.gov ↗
Wei Xie, Doctor
the chief of the neurology department, Southern Hospital of Southern Medical University
Study Chair
clinicaltrials.gov ↗
Xiaofei Yu
the chief of the neurology department, Shuguang Hospital of Shanghai University of Chinese Traditional Medicine
Study Chair
clinicaltrials.gov ↗
Yajun Jiang, Doctor
the chief of the neurology department, Chinese Traditional Medical Hospital of Jiangsu Province
Study Chair
clinicaltrials.gov ↗
Yefeng Cai, Master
the chief of the neurology department, Chinese Traditional Medical Hospital of Guangdong Province
Study Chair
clinicaltrials.gov ↗
Yingzhen Xie, Doctor
the chief of the neurology department, Dongzhimen Hospital
Study Chair
clinicaltrials.gov ↗
Yuangao Liao, Doctor
the chief of the neurology department, the First people's Hospital of Chenzhou
Study Chair
clinicaltrials.gov ↗
Zhijun Zhang, Doctor
the chief of the neurology department, Zhongda Hospital of Southeast University
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Beijing Friendship Hospital of Capital Medical University
Beijing, Beijing Municipality, China
Dongzhimen Hospital Affiliated To Beijing University of Chinese Traditional Medicine
Beijing, Beijing Municipality, China
Xuan Wu Hospital of Capital Medical University
Beijing, Beijing Municipality, China
Southern Hospital of Southern Medical
Guangzhou, Guangdong, China
the Chinese Traditional Medical Hospital of Guangdong Province
Guangzhou, Guangdong, China
the First Hospital of Hunan University of Chinese Traditional Medicine
Changsha, Hunan, China
the First People'S Hospital of Chenzhou
Chenzhou, Hunan, China
the Central Hospital of Baotou
Baotou, Inner Mongolia, China
Chinese Traditional Medical Hospital of Jiangsu Province
Nanjing, Jiangsu, China
the Zhongda Hospital of Southeast University
Nanjing, Jiangsu, China
the First Hospital of Jilin University
Changchun, Jilin, China
the Hospital of Traditional Chinese and Western Medicine of Jilin Province
Changchun, Jilin, China
the Shuguang Hospital of Shanghai University of Chinese Traditional Medicine
Shanghai, Shanghai Municipality, China
the Affiliated Hospital of Chengdu Chinese Traditional Medicine
Chengdu, Sichuan, China
the First Hospital of Tianjin University of Chinese Traditional Medicine
Tianjin, Tianjin Municipality, China
the First Hospital of Zhejiang University
Hangzhou, Zhejiang, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

High dose group of SaiLuoTong capsuleLow dose group of SaiLuoTongThe control group

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2011
Primary completion: 31 Jul 2014
Completion: 31 Jul 2014
Last update posted: 8 May 2014
Registered enrollment: 372
Registry id: NCT01978730

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.